News
FDA Grants Approval to BLENREP for Treating Multiple Myeloma
Pune, India | October 24, 2025 The recent U.S. Food and Drug Administration (FDA) approval of Blenrep (belantamab mafodotin-blmf) for adults with relapsed or refractory
Read More